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Abstract 
Functional magnetic resonance spectroscopy (fMRS) quantifies metabolic variations upon presentation of 
a stimulus and can therefore provide complementary information compared to functional magnetic 
resonance imaging (fMRI). However, to our knowledge, fMRS has not yet been performed in the mouse, 
despite that murine models are crucial for basic and applied research. Here, we performed fMRS 
experiments in the mouse, for the first time, and show the feasibility of such an approach for reliably 
quantifying metabolic variations. In particular, we observed metabolic variations in the superior colliculus 
of mice upon visual stimulation in a block paradigm commonly used for fMRI (short periods of stimulus), 
followed by a recovery period. We notably report a robust modulation of glutamate, as well as a 
modulation of NAAG, PCr and Cr. A control experiment with no stimulation reveals potential metabolic 
signal “drifts” that are not correlated with the functional activity, which should be taken into account 
when analyzing fMRS data in general. Our findings are promising for future applications of fMRS in the 
mouse.   
 
Highlights 
• Functional magnetic resonance spectroscopy is feasible in the sedated mouse. 
• A modulation of Glutamate is robustly observed in the mouse superior colliculus upon 
visual stimulation.  
• A GLM regression indicates that glutamate seems to be upregulated during the block-
paradigm but does not exhibit stimulus-locked variation with this design. 
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Introduction  
The complexity of brain function calls for diverse and complementary approaches capable of reporting on 
different aspects of neural activity. Functional magnetic resonance imaging (fMRI) is one of the most 
popular noninvasive techniques capable of studying human brain activity from a global brain perspective 
and with relatively high spatial resolution. Relying on neurovascular couplings as surrogate reporters for 
activity (Logothetis et al., 2001), fMRI can identify brain areas involved in a given task or in processing 
information. At higher fields, Blood Oxygen Level Dependent (BOLD) fMRI even allows for laminar 
resolution (Polimeni et al., 2010; Goense, Merkle and Logothetis, 2012), and, to some extent, specificity 
and insight into how the brain processes stimuli and integrates information. 
Despite its invaluable contributions to cognitive neuroscience and to clinical applications, BOLD 
fMRI is typically less specific in characterizing neural activity, mainly because of its indirect nature 
(Logothetis, 2008). For example, neither excitation and inhibition balances nor neuromodulatory effects 
can be specifically inferred from (typical) BOLD responses.  
Magnetic resonance spectroscopy (MRS) can provide noninvasive information on myriad 
molecules involved in brain metabolism if they are sufficiently concentrated (~mM) in vivo, thus endowing 
MRS with some level of specificity. Certain metabolites are concentrated in particular cell types (Urenjak 
et al., 1993; Belle et al., 2002; Griffin et al., 2002), making MRS more specific towards intracellular space 
compared to its water-driven MRI counterpart. Particularly interesting perhaps are MRS’s capabilities of 
probing glutamate (Glu) and γ-aminobutyric acid (GABA) – the main excitatory and inhibitory 
neurotransmitters in the brain, respectively. In addition, molecules involved in prominent metabolic 
pathways, such as glucose (Glc) and lactate (Lac), can be accessed using high-fidelity MRS. However, given 
the ~104 lower concentration of metabolites compared to water, MRS has a much lower sensitivity 
compared to water-based MRI, usually leading to long acquisition times and poor spatial resolution. 
Increasingly higher magnetic fields provide increasingly higher signal-to-noise, thereby overcoming some 
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of the sensitivity limitations; furthermore, higher magnetic fields also allow better spectral resolution, 
which can in turn increase the reliability of metabolite quantification (Mlynárik et al., 2008). However, the 
increased spectral bandwidths associated with higher fields also require high-power RF pulses or other 
alternatives (e.g. adiabatic pulses), which can then contribute to suboptimal SNR or increased SAR. 
Given the abovementioned challenges with MRS, it is perhaps not surprising that functional MRS 
(fMRS) experiments – i.e., MRS experiments designed to probe metabolites with high temporal resolution 
such that their variations during a task or upon a stimulus could be measured – remain quite rare. In 
humans, Mangia et al. (Mangia, Tkáč, Gruetter, et al., 2007; Mangia, Tkáč, Logothetis, et al., 2007) and 
then others (Lin et al., 2012; Schaller et al., 2014; Bednařík et al., 2015, 2018; Taylor et al., 2015; Betina 
Ip et al., 2017; Cao et al., 2017; Mekle et al., 2017; Martínez-Maestro, Labadie and Möller, 2018; Boillat 
et al., 2019) harnessed the increasing availability of high field 7 T scanners to record metabolic variations 
upon visual stimulation, often interpreted as a result of increased oxidative metabolism upon neural 
activity. Koush et al. (Koush et al., 2019) were able to probe lactate variations using J-Edited fMRS at 4 T. 
At more conventional fields of 3 T, fMRS acquisitions were carried out following some task-based stimuli 
(Apšvalka et al., 2015; Kühn et al., 2016), but also using acute pain stimuli (Gussew et al., 2010; Cleve, 
Gussew and Reichenbach, 2015) for which associated metabolic variations are larger (Mullins, 2018). In a 
majority of studies, increases in Glu (1-5%) (Mullins, 2018) and lactate  were evidenced in the active 
period. When spectral quantification was reliable enough, decreases in glucose and aspartate (Asp) levels 
were reported (Lin et al., 2012; Bednařík et al., 2015), as well as stimulus-dependent modulations in GABA 
levels (Cleve, Gussew and Reichenbach, 2015).  
Until now, the typical fMRS paradigms involved sustained (> 5 min) sensory stimulus, to facilitate 
signal averaging for robust quantification of metabolites during the active/resting states and to reach a 
metabolic steady state. However, habituation may play an important role in such sustained stimuli. In 
addition, the dynamics of such slow fMRS experiments can be difficult to interpret. Preclinical 
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experiments, with potentially much higher magnetic fields and their associated higher spectral resolution, 
as well as the availability of transgenic lines and possibility of performing more invasive validation 
experiments, can be extremely valuable to promote a better understanding and interpretation of fMRS. 
The first preclinical 1H-fMRS experiments were conducted in the rat (Just et al., 2013) still using sustained 
(> 10 min) stimuli, where increases in Glu and Lac and decreases in Glc could be observed despite the 
sedation. Since then, only very few other studies (Just and Sonnay, 2017; Sonnay, Duarte and Just, 2017; 
Sonnay et al., 2018; Just and Faber, 2019) have been performed in the rat and the tree shrew, generally 
reproducing the initial findings.  
The ease of manipulating the mouse genome and the consequent vast array of transgenic lines 
make mouse models highly important for basic research at large and for MRS research in particular. 
Optogenetic and chemogenetic mouse lines probing different cell types and circuits are available, as are 
many animal models of disease. However, insofar, fMRS studies have not been conducted in the mouse, 
to our knowledge. This can probably be traced to difficulties associated with the very small voxel sizes 
required for achieving regional specificity in mouse MRS (Tkáč et al., 2004), which would significantly 
reduce sensitivity. The difficulty is exacerbated by the need of a stable sedation (Grandjean et al., 2014), 
which can be more challenging in mice than in rats.  
In this study, we report the first – to our knowledge – functional 1H MRS experiments in the 
sedated mouse. As a simple proof of principle, we use visual stimulation and choose the superior colliculus 
(SC) as the target voxel, as it receives inputs directly from the optic tract and shows very robust BOLD 
responses upon simple visual stimuli. We use a relatively common preclinical field (9.4 T) but perform the 
experiments using a cryoprobe, which provides a facilitating ~2.5 increase in sensitivity compared with 
conventional reception coils. Furthermore, rather than using a sustained stimulus, we design a block 
paradigm with relatively short periods of stimulation (24s), that can alleviate adaptation and probe a 
different dynamic range which can potentially complement information arising from (water based) fMRI 
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responses. Our observations of robust fMRS responses are a steppingstone for future studies aiming to 
enhance the specificity of fMRI experiments in normal and diseased mice.   
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Material and methods  
All animal experiments were preapproved by the institutional and national authorities and carried out 
according to European Directive 2010/63.  
 
Animal sedation and preparation  
Anesthesia in mice (N = 20 C57Bl6 females, 3-4 months old, weighting 24-26g) was induced using ~5% 
isoflurane. The percentage of isoflurane was progressively decreased during animal preparation (namely, 
placing the animals on the animal bed and positioning the mouse using a bite bar and ear bars, 
medetomidine subcutaneous cannula and rectal probe insertion). The anesthesia regime was then 
switched to a mix of low dose isoflurane (~0.3%) in a 28% O2/air mixture and subcutaneous medetomidine 
infusion (bolus: 0.4mg/kg, constant infusion: 0.8mg/kg/h, optimized from (Grandjean et al., 2014)). 
Temperature (maintained at 36.0±0.5°C) and respiration rate were monitored throughout the 
experiments and remained stable once the functional spectroscopy session began.  
 
Experimental design  
Magnets and coils. All data were acquired using a 9.4 T Bruker BioSpec scanner (Bruker, Karlsruhe, 
Germany) interfaced with an AVANCE III HD console driving a gradient system capable of producing up to 
660 mT/m isotropically. The scanner runs on Paravision 6.0.1 software (Bruker, Ettlingen, Germany). An 
86 mm volume quadrature resonator scanner (Bruker, Karlsruhe, Germany) was used for transmission 
and a 4-elements array cryoprobe (Bruker, Fallanden, Switzerland) was used for signal reception.  
Setup for delivering visual stimuli. Optic fibers delivering a flashing blue light generated by a LED 
(wavelength = 470 nm, intensity = 0.8 W/m2, frequency = 4 Hz, pulse duration = 15 ms) were positioned 
horizontally on each side of the mouse bed at about 1cm to the eye.  
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Stimulation paradigm 
The block paradigm (BP) alternated between 48 sec without stimulation (OFF) and 24 sec with visual 
stimulation (ON) periods. This was repeated 5 times, followed by a single OFF period. For functional MRS 
acquisitions, the BP was followed by a recovery (R) period of the same duration (6 min 48 sec) for a total 
duration of 13 min 36 sec per BP-R paradigm.  
 
MRS pulse sequence adaptation  
Metabolites ranging from 1 to 4 ppm were targeted and observed in this study. Therefore, to ensure that 
the functional signals arise from the same voxel, chemical shift displacements needed to be minimized. 
To this end, a LASER (Localization by Adiabatic SElective Refocusing, (Garwood and Delabarre, 2001)) 
sequence was implemented and adapted for fMRS acquisitions in this study. In particular, the phase 
cycling of the LASER sequence, usually counting 32 to 64 steps for a good spurious signal removal 
(Kingsley, 1994), was reduced to 4 steps (excitation {0 2 1 3}, refocusing {1 3 0 2), receiver {0 2 1 3}) to 
allow a better temporal resolution. To compensate for the suboptimal phase cycling, 4 blocks of outer 
volume suppression (OVS) module were added prior to signal excitation.  
 
Timeline of experiments 
Figure 1A describes the principal experimental timeline for the functional experiment, which was 
designed to ensure robust visual activation throughout its entire duration. Below, we briefly mention each 
step and its role in the experimental design. Detailed parameters for pulse sequences used in each phase 
within the timeline are presented in the following section.  
Step 1: Blood Oxygenation Level Dependent (BOLD) fMRI (~7 min). Following routine 
adjustments, and a well resolved anatomical image for slices and voxel positioning, this simple experiment 
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was performed to ensure robust activation in the superior colliculus at the beginning of the experiment, 
following the BP. 
Step 2:  fMRS acquisitions (~1 h 10 min). Once a detectable BOLD-response was ascertained in 
the superior colliculus with a rapid analysis in PV6.0.1, we proceeded with the MRS acquisitions on upfield 
metabolites (with the water suppression module), following the BP-R, repeated 5 times. 
Step 3:  Repeated measurement of BOLD fMRI (~7 min). To ensure that habituation to stimulus 
in the superior colliculus is minimal, Step 1 was repeated and BOLD fMRI maps were measured again. 
Step 4: fMRS acquisition on the water signal (~7 min). To get the precise timing of vascular effects 
in the voxel of interest and correct for the vascular effect on metabolites during post-processing, identical 
fMRS experiments were performed on the water signal (by turning off the water suppression module). 
This also verified the voxel positioning and informed about LASER-driven water BOLD responses.  
Figure 1B describes the control experiment. The timeline is identical to the functional experiment’s 
timeline, except that no visual stimulation is delivered during Step 2, and Step 4 was not acquired (since 
vascular correction is irrelevant). For comparison with the above-mentioned BP-R paradigm, the 
“paradigm” of Step 2 for the control experiment was divided into two periods of 6 min 48 sec, that we 
termed “No Stim 1” and “No Stim 2”.  
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Figure 1. Representative timelines of the functional MRS experiment (A) and the control experiment (B). Both 
functional MRS and control experiments begin with a BOLD-fMRI acquisition upon visual stimulation, to verify the 
presence of a BOLD response in the superior colliculus in the beginning of the session (Step 1). Then, spectra are 
acquired in the superior colliculus during ~1h10min, concatenating 5 repetitions of the ensemble Block Paradigm - 
Recovery (A) or No Stim 1 - No Stim 2 (B) (Step 2). Another BOLD-fMRI map is acquired to verify the presence of a 
BOLD response in the superior colliculus in the end of the MRS session (Step 3) for both (A) and (B). In the functional 
MRS experiment (A) only, functional MRS of water is then acquired in the SC.  
 
Experimental parameters  
Steps 1 and 3: BOLD fMRI experiments were acquired using a gradient echo EPI pulse sequence (TR/TE = 
1000/12 ms), with an in-plane resolution of 0.145 × 0.145 mm2 (axial, matrix size 110 x 96, FOV=16 x 13.9 
mm2) and a slice thickness of 0.5 mm. The slice package (8 interleaved slices) was positioned to cover the 
superior colliculus and the visual cortex. The anatomical image was acquired using a T2-weighted RARE 
sequence (TE/TR = 40/2000 ms, resolution: 0.075 × 0.080 × 0.400 mm3, 15 interleaved slices). 
Step 2: fMRS experiments were carried out using the adapted LASER sequence (described above) on a 
volume of 2.3 × 1.7 × 1.7 mm3 voxel placed around the superior colliculus. Spectroscopic signals were 
collected over a bandwidth of 4000 Hz (10 ppm) with 2048 complex data points sampled (TE = 28 ms and 
TR = 1500 ms, total signal acquisition time = 512 ms). Hyperbolic secant (HS4) (Tannüs and Garwood, 
1996) refocusing pulses (pulse duration = 2 ms, bandwidth = 10 kHz) were designed using Topspin 3.1 
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(Bruker). Water suppression was achieved using a CHESS (CHEmical Shift Selective saturation, (Frahm et 
al., 1989)) module consisting of three CHESS pulses with a bandwidth of 250 Hz, chosen for having a 
shorter duration than the very efficient VAPOR (variable power RF pulses with optimized relaxation delays, 
(Tkáč et al., 1999)). The water residual amplitude was usually lower than twice the N-acetylaspartate 
(NAA) amplitude. The water suppression pulses were interleaved with 4 blocks of outer volume 
suppression sinc10 pulses, giving a total duration for the preparation modules of 227 ms. For each BP-R 
paradigm (or No Stim 1 – No Stim 2 paradigm), 544 repetitions were acquired over 13 min 36 sec (x5). The 
single voxel was shimmed between each block of 13 min 36 s. 
Step 4: Water fMRS was acquired using the same parameters as given above, only removing the water 
suppression module leading to 162 ms of preparation modules (OVS). 
 
Data Analysis.  
All data in this study were analyzed using custom code written in MATLAB® (The MathWorks, Inc., Natick, 
Massachusetts, United States). Below we elaborate on every data analysis routine for the relevant steps.  
 
Steps 1 and 3: BOLD-fMRI analysis 
The BOLD-fMRI map acquired in the beginning of the session was always analyzed on-the-fly with the 
vendor software (Paravision 6.0.1), to check if activity was detected in the superior colliculus before 
starting the MRS acquisitions. A more rigorous analysis with a home-made MATLAB® routine calling 
SPM12 was performed afterwards. Raw data were converted to Nifti, corrected for outliers, slice timing 
(taking for reference a slice comprising the superior colliculus) and motion (translation and rotation). 
Images were then isotropically smoothed using a 3D-Gaussian-kernel with FWHM=0.145 mm. Maps were 
fitted with a GLM (high-pass filter cutoff, 90s; motion parameters used as nuisance regressors) and 
thresholded at a significance level of p=0.01 and minimum cluster size=4. 
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Step 2: fMRS analysis  
Preprocessing. The phase cycling imposed a minimum time resolution of 4 repetitions (6 s). Repetitions 
were individually phase- and frequency-corrected taking as a reference the average spectrum with a 
MATLAB® home-made routine. For the sake of SNR, we summed spectra over 8 consecutive repetitions 
(each 4 repetitions) providing a moving average with an effective time resolution of 12 s (apparent time 
resolution 6 s). The resulting spectra were then eddy-current corrected in MATLAB® using the water 
reference (Klose, 1990) and the water residual signal (whose amplitude was usually not greater than twice 
the NAA or total creatine (tCr) peak) was removed by singular value decomposition (Pijnappel et al., 1992) 
to ensure a flat baseline. To correct for the potential linewidth and intensity slow drifts along time (1 h 08 
min of MRS acquisitions), we first concatenated the 5 blocks, normalized by their own intensity mean, to 
correct for potential gain variations between blocks. The data were then detrended by applying to 
successive spectra a linear linewidth correction, from the calculated averaged linewidth of the 3 singlets 
(NAA + tCr + choline compounds (tCho)), on individual blocks first (13 min 36 s) and then on the full time 
course (1 h 08 min). The average linewidths were computed by measuring the FWHM directly on the 
spectra, whose FIDs were zero filled prior to FT to improve the precision.   
 
Time course construction. To build the time course of interest (the block paradigm followed by the 
recovery period, 13 min 36 s), we summed the spectra coming from the corresponding time points from 
the 5 blocks (applying phase and frequency correction), giving a final time course of 135 points with an 
apparent time resolution of 6 s, and an effective time resolution of 12 s. Each spectrum representative of 
a time-point was calculated by adding the 8x5=40 individual repetitions, which allowed a robust 
metabolite quantification for individual animals. 
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Correction for BOLD-induced line narrowing. Positive BOLD responses in active areas can induce an 
increase in T2/T2* and therefore a linewidth narrowing, which in turn can bias the signal quantification. 
Under the hypothesis that BOLD effects would have a similar temporal dynamic on water and 
metabolite signals, we used the water fMRS measurements as a reference for BOLD-induced time courses, 
taking advantage of its high SNR. The linewidth and amplitude of the water signals were computed for the 
water fMRS experiments to spot the empirical timeline of the BOLD events (underlined in light grey on 
Figure 2B/2C). As an example, we corrected for the T2/T2* effect on water by applying a line-broadening 
of 0.4 Hz during the identified BOLD events. Temporal fluctuations of water linewidth due to BOLD 
activation were thus effectively removed (Figure 2C, right panel).  
 
Figure 2. BOLD responses upon visual stimulation delivered in a block paradigm (BP). (A) Animal-averaged BOLD 
fMRI maps acquired in the beginning and in the end of experiments, with a significance threshold of p=0.01. (B) 
Animal-averaged time course of the water linewidth acquired in the voxel around superior colliculus during the block 
paradigm (Step 4) without any correction, used to define the BOLD events, enhanced in light grey (upper left). A line 
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broadening of 0.4 Hz is applied during the defined BOLD events to exemplify the effect of such a correction (upper 
right). Animal-averaged time course of the water amplitude acquired in the voxel around superior colliculus during 
the block paradigm (Step 4) without any correction (lower left) or with a line broadening of 0.4 Hz applied during 
the predefined BOLD events (lower right). The shadows represent the standard deviations. 
 
The same approach was applied to the metabolites time courses (Figure 3). We computed the 
average linewidth and amplitude along the BP-R paradigm for the singlets of the upfield spectrum (NAA + 
tCr + tCho, Figure 3B/3C). We applied a line broadening of 0.5 Hz during the predefined BOLD events. 
Quantitatively, this correction equals at best the average linewidth during the BP and the average 
linewidth during the recovery period (Figure 3C). However, to account for cross-subject differences, we 
chose corrections individually for each animal (Figure 3A) by computing the difference between the 
averaged spectra of the BP and the Recovery periods, and applying a line broadening during the vascular 
events (between 0.5 and 0.7 Hz) that minimized the residuals of the 3 main singlets (Supplementary 
Figure 1A). Three (out of the 10) animals scanned for the functional experiment were detected as outliers: 
for these animals the nulling of the singlets’ residuals required a line broadening > 1 Hz, corresponding to 
a linewidth drift independent of a BOLD effect. In the control group, two outliers were detected 
(Supplementary Figure 1B). To make both the functional and the control experiment comparable in 
number, we removed these outliers and one more control mouse which had the poorest spectral quality, 
leaving N = 7 mice in each group.  
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Figure 3. Correcting BOLD effects on metabolite signals. (A) Example of T2* correction on a representative animal. 
A difference spectrum is generated from the difference between the average spectrum during the Block Paradigm 
(BP) (dark gray) and the Recovery period (light gray). The T2* correction was applied during the predefined BOLD 
events. The line broadening was chosen to visually minimize the residuals of NAA, tCr and tCho. The region below 
1.5 ppm is very variable, and should not be taken into account for interpretation. (B) Average amplitude of the 3 
singlets (NAA+tCr+tCho) computed from the time course of the all-animal-averaged spectra. The correction consists 
in a line broadening of 0.5 Hz applied during the predefined BOLD events (light gray). The light blue horizontal bars 
represent the periods of visual stimulation. (C) Average linewidth of the 3 singlets (NAA+tCr+tCho) computed from 
the time course of the all-animal-averaged spectra. The correction consists in a line broadening of 0.5 Hz applied 
during the predefined BOLD events (light gray). The correction was chosen to obtain the same average linewidth 
during the block paradigm and the recovery period. The light blue horizontal bars represent the periods of visual 
stimulation. 
 
Time course quantification. The BOLD-corrected fMRS spectra were quantified using LCModel 
(Provencher, 1993). A home-made routine based on the density matrix formalism (Mulkern and Bowers, 
1994) generated a basis set of 21 metabolites, using the chemical shift database proposed by 
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(Govindaraju, Young and Maudsley, 2000). An empirical macromolecule baseline was included in the basis 
set for a more robust spectral quantification (Giapitzakis et al., 2019). Macromolecule spectra were 
acquired during previous experiments in the same voxel by implementing a double inversion recovery 
module prior to the LASER localization block (first inversion time = 2200 ms, second inversion time = 700 
ms, chosen for the resulting good apparent metabolic nulling, close to (Lopez-kolkovsky, Sebastien and 
Boumezbeur, 2016)). All other parameters were identical to the MRS acquisitions (Step 2) except the TR 
that had to be prolonged to 4000 ms to incorporate the double inversion module. 
Spectra were fitted between 0.4 and 4.2 ppm. To obtain the normalized time course for every 
metabolite, the absolute concentration (as fitted by LCModel) was normalized by the corresponding 
average concentration during the recovery period (or during “No Stim 2” period for the control 
experiment) for every time point.   
 
Difference spectra. This analysis aimed at comparing the so-called “active period” (6 min 48 s of the BP) 
and the recovery period. We averaged spectra (with phase and frequency correction) from all time-points 
from the BOLD-corrected BP and subtracted the corresponding average spectrum from the recovery 
period. The same analysis was performed for the control experiment between the “No Stim 1” and “No 
Stim 2” periods.   
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Results 
Robust activation of the superior colliculus during the entire experimental duration   
BOLD-fMRI maps acquired prior to the fMRS experiments and after their completion are shown in Figure 
2A. Robust BOLD responses were observed in both instances, with similar spatial patterns. The contrast 
was occasionally somewhat weaker in the beginning of the experiment, likely because the isoflurane 
induction had not fully washed out yet. However, positive activation was always robustly observed in the 
superior colliculus, and in other visual areas such as the primary visual cortex and the lateral geniculate 
nucleus.  
Moreover, the clear BOLD responses observed in the time courses of the functional MRS acquisitions on 
water (Figure 2B) suggest the volume of interest was well positioned and with little chemical shift 
displacement. 
 
fMRS experiments - spectral quality 
The SNR of a spectrum at one time point (representative spectrum, Figure 4) were 27±3 for the NAA 
resonance at 2.0 ppm (corresponding average linewidth = 13.2±1.8 Hz),  29±3 for the tCr resonance at 3 
ppm (corresponding average linewidth = 12.9±1.1 Hz) and 28±3 for the tCho resonance at 3.2 ppm 
(corresponding average linewidth = 13.0±1.5 Hz). The chemical shift displacement between NAA (at 2 
ppm) and tCr (at 3 ppm) equals 4% (that is to say, 0.09 mm in the axial plan and 0.07 mm in the coronal 
and sagittal plans). The individual CRLB (Cramer-Rao Lower Bounds) were smaller than 5% on individual 
time points for NAA, tCr, tCho, myo-inositol (Ins), Glu, taurine (Tau) and macromolecules. The baseline 
fitted by LCModel was generally very flat, suggesting a good quality of localization, water suppression and 
macromolecular fit. 
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Figure 4. Representative spectrum of one time point (Recovery period) in one animal and the corresponding 
LCModel fit. The basis used for the linear combination incorporated 21 metabolites. The corresponding fit is shown 
for NAA, tCho (GPC + PCho + Cho), Glu, Ins.  
 
The difference spectrum reveals metabolic differences between the active period and the recovery 
period. 
To make the comparison possible between our results and the previous literature, we first considered the 
entire block paradigm as an “active” period, in contrast with the recovery period. The subtraction of the 
all-animal-averaged spectrum of the active period (corrected for vascular events as described in the 
Methods) and the all-animal-averaged spectrum of the recovery period is shown in Figure 5B, while the 
same analysis for the control experiment between No Stim 1 and No Stim 2 periods is shown in Figure 5A. 
The difference spectrum of the control experiment reveals non-vascular residuals for NAA, tCr and tCho, 
that can also be observed in the difference spectrum of the functional experiment. The principal 
difference between the two difference spectra is the robust residual at 2.3 ppm that we assign to 
glutamate. The region below 1.5 ppm was characterized by a large variability between animals 
(Supplementary Figure 1).  
19 
 
 
Figure 5. Spectral differences  (A) Difference spectrum between the all-animal-averaged spectrum of the No Stim 
1 period (dark grey) and the No Stim 2 period (light grey). The region below 1.5 ppm is very variable, and should not 
be taken into account for interpretation. (B) Difference spectrum between the all-animal-averaged spectrum of the 
Block Paradigm (dark grey) and the Recovery period (light grey). The region below 1.5 ppm is very variable, and 
should not be taken into account for interpretation 
 
To compare the active period with the recovery period, we also computed the concentration 
distributions of metabolites for the BP and the recovery period, each value corresponding to 1 time point 
in 1 animal. Histograms for Glu, Ins, tCho and Glu are shown in Figure 6B (Tau and tCr in Supplementary 
Figure 2). Similarly, we compared No Stim 1 and No Stim 2 (Figure 6C).  A consistent increase of glutamate 
during the block paradigm can be seen via a clear shift towards higher concentrations in the first part of 
the functional experiment, while there is no shift in the control distribution. Otherwise, a slight drift is 
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bserved for NAA (and Tau) in both the functional and control experiments. tCr exhibits a stronger drift in 
the control experiment than in the functional experiment.  
 
Figure 6. Time course analysis (A) Relative concentrations time-courses for Glu (red), Ins (yellow), tCho (green) 
and tNAA (blue) during the Block Paradigm (BP) and the Recovery period, normalized by their mean during the 
Recovery period. The dotted gray line represents the coefficient of variation of the data calculated from the standard 
deviation and the mean during the Recovery period. The light blue horizontal bars represent the periods of visual 
stimulation. (B) Relative concentrations distributions for Glu (red), Ins (yellow), tCho (green) and tNAA (blue) during 
the Block Paradigm (BP) and the Recovery period, normalized by their mean during the Recovery period. 
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Dynamic time courses of reliable metabolites (CRLB < 5%), time resolution 12s 
The average time courses of NAA, tCr, tCho, Glu, Ins and Tau were computed from the individual time 
courses of the functional and control experiments (Figure 6A, Supplementary Figure 2). To account for 
the different noise levels of the different metabolites, we compare the metabolic variation with the 
coefficient of variation (CoV) defined during the recovery period (respectively the “No Stim 2” period) and 
represented it on the time courses by a dotted gray line. Glutamate is progressively upregulated during 
the visual stimulation. As for the inference of a more dynamic information, there does not seem to be an 
increase in glutamate locked to the short periods of stimuli (24 s, highlighted in light blue on Figure 6A), 
but the noise level prevents drawing more qualitative conclusions. The other metabolites present similar 
time courses between the functional and the control experiment, except for tCr, whose drift is stronger 
in the control experiment (Supplementary Figure 2).  
Despite their much higher CRLB, time courses and distributions of N-acetylaspartateglutamate 
(NAAG) (mean CRLB = 10), PCr (mean CRLB = 7) and Cr (mean CRLB = 11) are displayed in Supplementary 
Figure 3, for their (qualitative) different patterns between the functional and the control experiment. 
Notably we notice a downregulation of NAAG during the block paradigm and an upregulation of creatine 
(Cr), and slight downregulation of phosphocreatine (PCr). 
 
Generalized Linear Model (GLM) regression on time courses. 
To get a more quantitative dynamic analysis, that the good time resolution theoretically allows, we ran a 
simple GLM regression on the average time courses of NAA, tCr, tCho, Glu, Ins and Tau. The GLM 
incorporated the block paradigm, the active/recovery design to assess for slow metabolic response, and 
a linear drift (Figure 7C). After a multiple comparison correction, NAA varied significantly with the block 
paradigm during the functional experiment, while Glutamate varied significantly only with the 
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active/recovery design. During the control experiment, NAA, tCr, tCho exhibited a significant drift (Table 
1). 
With a finite impulse response approach (13 blocks of 1min), we also estimated the “metabolic response 
function” (MRF) of the different metabolites, as it can be seen on Figure 7A. Glutamate MRF ramps up 
until the second period of stimulation (~3min) and decreases in the end of the BP. In comparison, the 
other metabolites do not exhibit MRF with a specific pattern.  
 
Figure 7. General Linear Model (A) Metabolic response function estimated for Glu, NAA, tCho and Ins with the Finite 
Impulse Response approach. (B) The regressor matrix for (A) contains 13 regressors. Each regressor consists in a step 
of ones of 1 min. (C) The regressor matrix corresponding to the GLM analysis whose results are shown in Table 1 
contains 3 regressors: a linear drift (lower row), the block paradigm design (middle row) and active/recovery design 
(upper row).   
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Discussion 
In this work, we developed functional magnetic resonance spectroscopy experiments in mice. The mouse 
model is important for many disease models and is amenable to genetic manipulation; thereby, future 
studies using mouse fMRS could contribute to understanding of fMRS signals observed in humans and to 
interpret the ensuing metabolic variations. For example, several studies interpret variations of Glu, but 
more particularly GABA, as reporters of excitation or inhibition mechanisms, respectively (Cleve, Gussew 
and Reichenbach, 2015; Mekle et al., 2017; Stanley and Raz, 2018; Bezalel, Paz and Tal, 2019; Boillat et 
al., 2019), potentially making fMRS attractive for psychiatric diseases, where an altered 
excitation/inhibition balance is often pointed out (Marín, 2012). The availability of mouse models and 
their amenability towards concomitant or post-hoc invasive procedures, as well as the increasing 
availability of preclinical high field MRI scanners with high-performing probes can thus bridge the gap, and 
assist in explaining the nature of observed modulations. Optogenetics lines expressing channel rhodopsin 
specifically in glutamatergic or GABAergic neurons (Zhao et al., 2011) could help disentangling the role of 
excitatory and inhibitory neurons in signal change (n.b. a recent study combining optogenetic and fMRS 
in rats (Just and Faber, 2019)). Moreover the well-established pharmacology available in rodents, and the 
chemical genetic lines (such as DREADDs, (Roth, 2016)) are preclinical tools allowing, among others, 
manipulations of diverse cell metabolic pathways or of synaptic release, and therefore have the potential 
to unravel the nature of the fMRS modulation. The increasing number of mouse models of psychiatric and 
neurodegenerative diseases reinforces the interest for translational approaches with functional magnetic 
resonance spectroscopy. 
The robust increase of glutamate measured during the block paradigm is in good agreement with 
previous fMRS literature, in humans and in rodents. As the main excitatory neurotransmitter and 
abundant amino acid in the adult mammalian brain, glutamate is involved in numerous metabolic 
pathways (Danbolt, 2001; Magistretti and Allaman, 2015). It is mostly present in the cytoplasm, but is also 
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densely located in synaptic vesicles, in mitochondria and in the synaptic cleft. Commonly associated to 
neurons in the CNS, glutamate also enters briefly in astrocytes through the glutamate-glutamine cycle. 
Therefore, we cannot assert the origin of the observed glutamate upregulation in our experiment.  
However, the GLM analysis (Table 1 and Figure 7) suggests that the modulation is not stimulation-locked, 
as would neurotransmission events with fast dynamics be, but rather reflects a relatively slow dynamic, 
possibly corresponding to a metabolic adaptation. Since the different glutamate pools might have 
different relaxation and diffusion properties, the upregulation can match an increased glutamate 
production, or a different compartmentalization.  
The more subtle decrease of NAAG becomes quite consistent when adding the observations from 
the difference spectrum (Figure 5B) and from the time courses and distributions. NAAG is a neuropeptide 
particularly concentrated in the inhibitory layers of the SC (Tsai et al., 1993), that may serve as an 
antagonist and a precursor of glutamate (Robinson et al., 1987). Therefore, a parallel variation of NAAG 
and glutamate in this region is perhaps not very surprising.  
Our relatively good spectral resolution disentangles PCr from Cr (with the 4ppm resonance). Some 
functional 31P MRS studies rather report an increase in the PCr signal during visual stimulation in the 
human brain. In a recent study (Hendriks et al., 2019), the authors report an increase in PCr amplitude, 
but a decrease in linewidth during periods of stimulation, and therefore describe it as a BOLD effect.  In 
(van de Bank et al., 2018), the authors report an increase in the PCr amplitude, but no linewidth 
modulation during stimulation, claiming that PCr is upregulated during stimulation independently of a 
BOLD effect. However, PCr is a source of phosphate for ATP production through creatine kinase, and 
interestingly we observe a downregulation of PCr (and a consistent upregulation of Cr) more particularly 
in the beginning of the block paradigm. The phosphate of the PCr could be used to regenerate ATP, as a 
primary metabolic response. This result is consistent with a recent study achieved in the sedated tree 
shrew at 14.1 T (Sonnay et al., 2018). 
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In comparison to several fMRS studies that report an increase of lactate during the active period 
(Mangia, Tkáč, Logothetis, et al., 2007; Gussew et al., 2010; Lin et al., 2012; Schaller et al., 2013; Just et 
al., 2013; Bednařík et al., 2015, 2018; Just and Sonnay, 2017; Mekle et al., 2017; Boillat et al., 2019; Koush 
et al., 2019), we do not report such an increase. Several reasons can explain this difference. Most of the 
studies reporting a lactate increase during an active period delivered a sustained stimulus (> 2 min) or a 
prolonged task. In our work, the visual stimulus was delivered through a block paradigm with repeated 
short periods of visual stimulation (24s), and not through a sustained or very long stimulus, where lactate 
might accumulate in the cell before being cleared out. Additionally, the superior colliculus is a subcortical 
region of the brain, and previous studies usually observed the response in the cortical area associated to 
the sensory stimulus. In a recent rat fMRS study, metabolic changes upon a trigeminal nerve stimulation 
were observed and while an increase of lactate concentration in the somatosensory cortex was reported, 
similar thalamic variations were not reported (Just and Sonnay, 2017). The lactate increase is sometimes 
associated with the activity of the astrocyte-neuron (particularly excitatory) lactate shuttle. Any variation 
in cell-type distribution (astrocytes, inhibitory and excitatory neurons) may affect the underlying regional 
metabolism. We also cannot rule out that the anesthesia here used (specifically, a combination of 
medetomidine and isoflurane), could underlie differences in metabolic regimes. A recent study using 
medetomidine in rats (unlike most other studies that used alpha-chloralose) does not report changes in 
lactate during sensory or optogenetic stimulation (Just and Faber, 2019). 
Our work points out the importance of a control experiment characterizing the time course of 
metabolites during long periods, as signal drifts may “masquerade” as activation (Figure 6, 
Supplementary Figures 2 and 3). Despite the shim drift correction, there might also be a metabolic drift, 
since anesthetics are affecting metabolism and measured metabolites concentrations (Boretius et al., 
2013). 
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The LCModel quantifies metabolites using the NMR signature area of each metabolite, that 
accounts for the linewidth shape, and therefore should be insensitive to T2* variation. However, some 
simple simulations (applying a variable line broadening on one spectrum) show that the concentration of 
some metabolites given by LCModel is affected by a linewidth difference of 0.5 Hz (up to 1-2%), and even 
more intensely with noisy spectra. Therefore, the correction for T2* effect (Figure 2 and 3) associated to 
the neurovascular coupling is a crucial postprocessing step, but the method is empirical and subsequently 
far from ideal. The line broadening in this study was applied to correct for T2* effect on NAA, tCho and 
tCr together; however, the linewidth of these metabolites might change slightly differently depending on 
their compartmentation and their proximity to vessels. Other non-vascular mechanisms could also change 
their T2 dynamically (relative change in compartmentation for example), suggesting that more robust T2* 
correction methods should be developed.  
Finally, limitations associated to single voxel MRS and sedated animals also affect this study. The 
superior colliculus has a very heterogeneous structure, composed of 7 layers, with different types of 
neurons (May, 2006). The visual input arrives in the superficial layers of the SC (in the 3rd layer), and 
provokes an excitation followed by an inhibition from neurons in the 2nd layer. The volume of interest is 
placed around the complete structure (i.e. the 7 layers), and our measurements necessarily suffer from 
partial volume effect and heterogenous neuronal response. The use of sedation is also a confounding 
factor that might modulate metabolism and neurotransmission. Medetomidine is an α2-adrenergic 
agonist, however the density of α2-adrenergic receptors is quite low in the SC (Wang et al., 1996), so the 
effect should be mostly indirect. Isoflurane binds to many receptors and its action mechanism is not 
clearly established, however we use it at very low dose (0.3%) to stabilize the medetomidine sedation, 
moderating its impact.  
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Conclusion 
Functional magnetic resonance spectroscopy was successfully developed and applied in the sedated 
mouse. Consistent glutamate increases were measured in the superior colliculus upon visual stimulation, 
delivered with a block paradigm that can be equally used for BOLD-fMRI. The effective time resolution (12 
s) and our paradigm design (discontinuous stimulation) enabled a dynamic analysis with a GLM commonly 
used in fMRI analysis. Under our experimental conditions, the glutamate modulation measured by MRS is 
not locked to the stimulus and is likely partially independent from the neurotransmission events. This 
study opens the door for the exploration and application of fMRS in the mouse, the richest mammalian 
animal model in terms of genetic lines and pharmacological tools.  
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Figures captions  
Figure 1. Representative timelines of the functional MRS experiment (A) and the control experiment (B). 
Both functional MRS and control experiments begin with a BOLD-fMRI acquisition upon visual stimulation, 
to verify the presence of a BOLD response in the superior colliculus in the beginning of the session (Step 
1). Then, spectra are acquired in the superior colliculus during ~1h10min, concatenating 5 repetitions of 
the ensemble Block Paradigm - Recovery (A) or No Stim 1 - No Stim 2 (B) (Step 2). Another BOLD-fMRI 
map is acquired to verify the presence of a BOLD response in the superior colliculus in the end of the MRS 
session (Step 3) for both (A) and (B). In the functional MRS experiment (A) only, functional MRS of water 
is then acquired in the SC.  
 
Figure 2. BOLD responses upon visual stimulation delivered in a block paradigm (BP). (A) Animal-averaged 
BOLD fMRI maps acquired in the beginning and in the end of experiments, with a significance threshold 
of p=0.01. (B) Animal-averaged time course of the water linewidth acquired in the voxel around superior 
colliculus during the block paradigm (Step 4) without any correction, used to define the BOLD events, 
enhanced in light grey (upper left). A line broadening of 0.4 Hz is applied during the defined BOLD events 
to exemplify the effect of such a correction (upper right). Animal-averaged time course of the water 
amplitude acquired in the voxel around superior colliculus during the block paradigm (Step 4) without any 
correction (lower left) or with a line broadening of 0.4 Hz applied during the predefined BOLD events 
(lower right). The shadows represent the standard deviations. 
 
 
Figure 3. Correcting BOLD effects on metabolite signals. (A) Example of T2* correction on a representative 
animal. A difference spectrum is generated from the difference between the average spectrum during the 
Block Paradigm (BP) (dark gray) and the Recovery period (light gray). The T2* correction was applied 
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during the predefined BOLD events. The line broadening was chosen to visually minimize the residuals of 
NAA, tCr and tCho. The region below 1.5 ppm is very variable, and should not be taken into account for 
interpretation. (B) Average amplitude of the 3 singlets (NAA+tCr+tCho) computed from the time course 
of the all-animal-averaged spectra. The correction consists in a line broadening of 0.5 Hz applied during 
the predefined BOLD events (light gray). The light blue horizontal bars represent the periods of visual 
stimulation. (C) Average linewidth of the 3 singlets (NAA+tCr+tCho) computed from the time course of 
the all-animal-averaged spectra. The correction consists in a line broadening of 0.5 Hz applied during the 
predefined BOLD events (light gray). The correction was chosen to obtain the same average linewidth 
during the block paradigm and the recovery period. The light blue horizontal bars represent the periods 
of visual stimulation. 
 
 
Figure 4. Representative spectrum of one time point (Recovery period) in one animal and the 
corresponding LCModel fit. The basis used for the linear combination incorporated 21 metabolites. The 
corresponding fit is shown for NAA, tCho (GPC + PCho + Cho), Glu, Ins.  
 
Figure 5. Spectral differences  (A) Difference spectrum between the all-animal-averaged spectrum of the 
No Stim 1 period (dark grey) and the No Stim 2 period (light grey). The region below 1.5 ppm is very 
variable, and should not be taken into account for interpretation. (B) Difference spectrum between the 
all-animal-averaged spectrum of the Block Paradigm (dark grey) and the Recovery period (light grey). The 
region below 1.5 ppm is very variable, and should not be taken into account for interpretation 
 
Figure 6. Time course analysis (A) Relative concentrations time-courses for Glu (red), Ins (yellow), tCho 
(green) and tNAA (blue) during the Block Paradigm (BP) and the Recovery period, normalized by their 
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mean during the Recovery period. The dotted gray line represents the coefficient of variation of the data 
calculated from the standard deviation and the mean during the Recovery period. The light blue horizontal 
bars represent the periods of visual stimulation. (B) Relative concentrations distributions for Glu (red), Ins 
(yellow), tCho (green) and tNAA (blue) during the Block Paradigm (BP) and the Recovery period, 
normalized by their mean during the Recovery period. 
 
Figure 7. General Linear Model (A) Metabolic response function estimated for Glu, NAA, tCho and Ins with 
the Finite Impulse Response approach. (B) The regressor matrix for (A) contains 13 regressors. Each 
regressor consists in a step of ones of 1 min. (C) The regressor matrix corresponding to the GLM analysis 
whose results are shown in Table 1 contains 3 regressors: a linear drift (lower row), the block paradigm 
design (middle row) and active/recovery design (upper row).   
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Table 1: p-values for the GLM analysis achieved on metabolites time courses for both the functional and 
the control experiment, whose regressors are described in Figure 7C. p-values < 0.05 are highlighted in 
bold. When applying a Bonferroni correction for multiple comparison (6 metabolites), the p-values 
becoming > 0.05 are highlighted in bold + italic. 
 FUNCTIONAL CONTROL 
 Drift Block Paradigm Active/Recovery Drift Block Paradigm Active/Recovery 
NAA 0.019 0.003 0.081 1.07E-05 0.131 0.24 
tCr 0.116 0.015 0.567 2.54E-04 0.817 0.718 
tCho 0.756 0.133 0.552 0.00498 0.14 0.548 
Glu 0.812 0.512 0.0041 0.0451 0.053 0.834 
Ins 0.467 0.222 0.733 0.35 0.989 0.539 
Tau 0.122 0.629 0.67 0.206 0.025 0.371 
 
